Food and Drug Administration officials are pushing for a "black box" warning about the risk of suicidal thoughts and behavior with epilepsy drugs, just days ahead of a public meeting on the issue.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to US FDA urging black box warning for epilepsy drugs
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account